Drug Enforcement Administration (DEA), Department of Justice.
This notice establishes the initial 2014 aggregate production quotas for three temporarily controlled synthetic phenethylamines, 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe.
Effective Date: April 1, 2014.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
Ruth A. Carter, Office of Diversion Control, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152, Telephone: (202) 598-6812.
End Further Info
Start Supplemental Information
Section 306 of the Controlled Substances Act (CSA) (21 U.S.C. 826) requires the Attorney General to establish aggregate production quotas for each basic class of controlled substance listed in schedules I and II and for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. The Attorney General has delegated this authority to the Administrator of the DEA, 28 CFR 0.100, who in turn has redelegated that authority to the Deputy Administrator of the DEA, 28 CFR part 0, subpt. R, App.
On November 15, 2013, the DEA published in the Federal Register a final order to temporarily place three synthetic phenethylamines, 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe, into schedule I of the CSA (78 FR 68716), making all regulations pertaining to schedule I controlled substances applicable to the manufacture of 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe, including the requirement to obtain a manufacturing quota pursuant to 21 CFR part 1303.
The 2014 aggregate production quotas for 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe represent those quantities to be manufactured in the United States in 2014 to provide for the estimated medical, scientific, research, and industrial needs of the United States, lawful export requirements, and the establishment and maintenance of reserve stocks.
On January 30, 2014, the DEA published a notice titled, “Controlled Substances: 2014 Proposed Aggregate Production Quota for Three Temporarily Controlled Synthetic Phenethylamines” in the Federal Register (79 FR 4958). That notice proposed the 2014 aggregate Start Printed Page 18318production quotas for 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe. Interested persons were invited to comment on or object to the proposed aggregate production quotas for 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe on or before March 3, 2014. No comments were received.
Analysis for 2014 Established Aggregate Production Quotas
In determining the 2014 aggregate production quotas for 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe, the DEA has taken into consideration the factors set forth at 21 CFR 1303.11, pursuant to 21 U.S.C. 826(a), and other relevant factors, including 2014 export requirements, industrial use, applications for quotas, as well as information on research and product development requirements.
Pursuant to 21 U.S.C. 826 and in accordance with 21 CFR 1303.11, the Deputy Administrator hereby establishes the 2014 aggregate production quotas for the 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe, expressed in grams of anhydrous acid or base, as follows:
|Basic class—schedule I||Established 2014 quota|
|2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36)||15 g.|
|2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82)||15 g.|
|2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5)||15 g.|
In accordance with 21 CFR 1303.13, upon consideration of the relevant factors, the Deputy Administrator may adjust the 2014 aggregate production quotas for 25B-NBOMe, 25C-NBOMe, and 25I-NBOMe as needed.
End Supplemental Information
Dated: March 24, 2014.
Thomas M. Harrigan,
[FR Doc. 2014-07170 Filed 3-31-14; 8:45 am]
BILLING CODE 4410-09-P